Literature DB >> 2539524

Differences in replication of attenuated and neurovirulent polioviruses in human neuroblastoma cell line SH-SY5Y.

N La Monica1, V R Racaniello.   

Abstract

A base change from C to U at position 472 of the 5' noncoding region of the poliovirus genome is known to be a major determinant of attenuation in the P3/Sabin vaccine strain. To determine the biochemical basis for the attenuated phenotype imparted by this mutation, a cell line in which replication of neurovirulent and attenuated viruses could be distinguished was identified. A pair of P3/Sabin-P2/Lansing viral recombinants that differ only at position 472 was used; the viruses replicated equally well in HeLa cells, but the virus with a U at base 472 was attenuated in mice. In the human neuroblastoma cell line SH-SY5Y, recombinants with a U at base 472 replicated to approximately 10-fold-lower titers than did neurovirulent viruses with a C at this position. Analysis of viral RNA and protein synthesis indicated that translation of the attenuated viral RNA was specifically reduced in SH-SY5Y cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2539524      PMCID: PMC250657     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  12 in total

Review 1.  Poliovirus neurovirulence.

Authors:  V R Racaniello
Journal:  Adv Virus Res       Date:  1988       Impact factor: 9.937

2.  The genomes of attenuated and virulent poliovirus strains differ in their in vitro translation efficiencies.

Authors:  Y V Svitkin; S V Maslova; V I Agol
Journal:  Virology       Date:  1985-12       Impact factor: 3.616

3.  Aspects of the synthesis of poliovirus RNA and the formation of virus particles.

Authors:  D Baltimore; M Girard; J E Darnell
Journal:  Virology       Date:  1966-06       Impact factor: 3.616

4.  Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture.

Authors:  J L Biedler; L Helson; B A Spengler
Journal:  Cancer Res       Date:  1973-11       Impact factor: 12.701

5.  A mouse model for poliovirus neurovirulence identifies mutations that attenuate the virus for humans.

Authors:  N La Monica; J W Almond; V R Racaniello
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

6.  Site-directed mutagenesis of proteinase 3C results in a poliovirus deficient in synthesis of viral RNA polymerase.

Authors:  P G Dewalt; B L Semler
Journal:  J Virol       Date:  1987-07       Impact factor: 5.103

7.  Poliovirus temperature-sensitive mutant containing a single nucleotide deletion in the 5'-noncoding region of the viral RNA.

Authors:  V R Racaniello; C Meriam
Journal:  Virology       Date:  1986-12       Impact factor: 3.616

8.  Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome.

Authors:  D M Evans; G Dunn; P D Minor; G C Schild; A J Cann; G Stanway; J W Almond; K Currey; J V Maizel
Journal:  Nature       Date:  1985 Apr 11-17       Impact factor: 49.962

9.  Mapping of attenuating sequences of an avirulent poliovirus type 2 strain.

Authors:  E G Moss; R E O'Neill; V R Racaniello
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

10.  Effects of phorbol ester tumor promoters and nerve growth factor on neurite outgrowth in cultured human neuroblastoma cells.

Authors:  W Spinelli; K H Sonnenfeld; D N Ishii
Journal:  Cancer Res       Date:  1982-12       Impact factor: 12.701

View more
  84 in total

1.  Mapping the genetic determinants of pathogenicity and plaque phenotype in swine vesicular disease virus.

Authors:  T Kanno; D Mackay; T Inoue; G Wilsden; M Yamakawa; R Yamazoe; S Yamaguchi; J Shirai; P Kitching; Y Murakami
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

2.  Cell-specific proteins regulate viral RNA translation and virus-induced disease.

Authors:  E V Pilipenko; E G Viktorova; S T Guest; V I Agol; R P Roos
Journal:  EMBO J       Date:  2001-12-03       Impact factor: 11.598

Review 3.  Viral internal ribosome entry site elements: novel ribosome-RNA complexes and roles in viral pathogenesis.

Authors:  Peter Sarnow
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

4.  Differentiated neuroblastoma cells provide a highly efficient model for studies of productive varicella-zoster virus infection of neuronal cells.

Authors:  Jenna Christensen; Megan Steain; Barry Slobedman; Allison Abendroth
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

5.  Activity of a type 1 picornavirus internal ribosomal entry site is determined by sequences within the 3' nontranslated region.

Authors:  Elena Dobrikova; Paola Florez; Shelton Bradrick; Matthias Gromeier
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-26       Impact factor: 11.205

6.  Postinfection treatment with antiviral serum results in survival of neural cells productively infected with virulent poliovirus.

Authors:  E A Tolskaya; T A Ivannikova; M S Kolesnikova; S G Drozdov; V I Agol
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

7.  Correlation of mutations and recombination with growth kinetics of poliovirus vaccine strains.

Authors:  V Pliaka; Z Kyriakopoulou; D Tsakogiannis; I G A Ruether; C Gartzonika; S Levidiotou-Stefanou; A Krikelis; P Markoulatos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-09-05       Impact factor: 3.267

8.  Persistent poliovirus infection of human neuroblastoma cells.

Authors:  F Colbère-Garapin; C Christodoulou; R Crainic; I Pelletier
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

9.  An attenuating mutation in the 2A protease of swine vesicular disease virus, a picornavirus, regulates cap- and internal ribosome entry site-dependent protein synthesis.

Authors:  Y Sakoda; N Ross-Smith; T Inoue; G J Belsham
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

10.  Low efficiency of the 5' nontranslated region of hepatitis A virus RNA in directing cap-independent translation in permissive monkey kidney cells.

Authors:  L E Whetter; S P Day; O Elroy-Stein; E A Brown; S M Lemon
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.